Fidelis Capital Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
4,794
+611
| +15% | +$27.7K | 0.02% | 410 |
|
|
2025
Q1 | $260K | Sell |
4,183
-10,146
| -71% | -$630K | 0.03% | 347 |
|
|
2024
Q4 | $1.18M | Sell |
14,329
-5,984
| -29% | -$495K | 0.12% | 146 |
|
|
2024
Q3 | $2.35M | Buy |
20,313
+10,500
| +107% | +$1.22M | 0.28% | 67 |
|
|
2024
Q2 | $1.17M | Buy |
9,813
+573
| +6% | +$68.3K | 0.17% | 111 |
|
|
2024
Q1 | $1.19M | Buy |
+9,240
| New | +$1.19M | 0.18% | 104 |
|